This article is not available in the selected language.
Currently displaying in English.
SELLAS Life Sciences shares plunge 19%: What triggered the sharp sell-off?
SELLAS Life Sciences shares plunge 19%: What triggered the sharp sell-off? - Visual Report
SELLAS Life Sciences shares plunged nearly 20% after the biotechnology company priced a $150 million public offering at $13 per share, a discount of around 28% to its previous close. The sell-off f...
owed a sharp rally triggered by positive Phase 3 REGAL trial results for its experimental leukemia vaccine....



Reader Comments (0)
No approved comments yet. Be the first to share your thoughts!